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Ave., Cincinnati, Ohio 45229-3026.Purpose: Based on a genome-wide association study of testicular dysgenesis
syndrome showing a possible association with TGFBR3, we analyzed data from
a larger, phenotypically restricted cryptorchidism population for potential
replication of this signal.
Materials and Methods: We excluded samples based on strict quality control
criteria, leaving 844 cases and 2,718 controls of European ancestry that were
analyzed in 2 separate groups based on genotyping platform (ie Illumina
HumanHap550, version 1 or 3, or Human610-Quad, version 1 BeadChip in group
1 and Human OmniExpress 12, version 1 BeadChip platform in group 2). Anal-
yses included genotype imputation at the TGFBR3 locus, association analysis
of imputed data with correction for population substructure, subsequent
meta-analysis of data for groups 1 and 2, and selective genotyping of independent
cases (330) and controls (324) for replication. We also measured Tgfbr3
mRNA levels and performed TGFBR3/betaglycan immunostaining in rat fetal
gubernaculum.
Results: We identified suggestive (p 1104) association of markers in/near
TGFBR3, including rs9661103 (OR 1.40; 95% CI 1.20, 1.64; p ¼ 2.71105) and
rs10782968 (OR 1.58; 95% CI 1.26, 1.98; p ¼ 9.36105) in groups 1 and 2,
respectively. In subgroup analyses we observed strongest association of
rs17576372 (OR 1.42; 95% CI 1.24, 1.60; p ¼ 1.67104) with proximal
and rs11165059 (OR 1.32; 95% CI 1.15, 1.38; p ¼ 9.42104) with distal testis
position, signals in strong linkage disequilibrium with rs9661103 and
rs10782968, respectively. Association of the prior genome-wide association
study signal (rs12082710) was marginal (OR 1.13; 95% CI 0.99, 1.28; p ¼ 0.09 for
group 1), and we were unable to replicate signals in our independent cohort.
Tgfbr3/betaglycan was differentially expressed in wild-type and cryptorchid
rat fetal gubernaculum.
Conclusions: These data suggest complex or phenotype specific association
of cryptorchidism with TGFBR3 and the gubernaculum as a potential target
of TGFb signaling.0022-5347/15/1935-1637/0
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tified in boys at birth or during childhood. The
etiology is poorly understood and likely multifacto-
rial, although associated genetic loci remain largely
unknown. Familial aggregation suggests moderate
genetic susceptibility and implicates the maternal
environment as contributory to cryptorchidism
risk.1,2 Level of familial risk in this disorder
exceeds that for many complex diseases and pre-
dicts the potential for greater success in genome-
wide analyses.3
Testicular descent is regulated by insulin-like
3 and androgens, Leydig cell derived hormones
that control development of the fetal gubernac-
ulum.4 Exonic variants of INSL3, its receptor
relaxin/insulin-like family peptide receptor 2
(RXFP2) or other hormone pathway genes are rare
in cryptorchidism cases, and their functional sig-
nificance is poorly defined.5 Dalgaard et al per-
formed a GWAS augmented by systems biology
analysis methodology to identify genetic markers
linked to the testicular dysgenesis syndrome, which
includes cryptorchidism, hypospadias, testicular
cancer and infertility.6 This approach did not iden-
tify genome-wide significant signals, but had
limited power to detect loci associated with isolated
cryptorchidism. However, a TGFBR3 intronic single
nucleotide polymorphism, rs12082710, demon-
strated evidence suggestive of association with TDS
and cryptorchidism. Accordingly we focused on
TGFBR3 in an initial analysis of data from a larger
GWAS cohort, and observed suggestive, phenotype-
specific association of nonsyndromic cryptorchidism
with this locus.MATERIAL AND METHODS
Subjects and Genotyping
Subjects included boys with cryptorchidism who under-
went surgical repair at Nemours/Alfred I. duPont
Hospital for Children or the Children’s Hospital of Phil-
adelphia. Exclusion criteria consisted of multiple
congenital anomalies and/or diagnosis of a syndrome,
other genital anomalies (hypospadias, chordee or other
penile anomalies) and abdominal wall defects or major
urogenital malformations. Control subjects recruited
through the Children’s Hospital of Philadelphia Care
Network were males 7 years or older without a history of
testicular disease, syndromes or other medical disorders
potentially associated with cryptorchidism, including
inguinal hernia and hypospadias.
Basic demographic and phenotypic data were collected,
including age at diagnosis, race, ethnicity, laterality
and position of the affected testis. Blood sample or excesstissue was collected and stored at 80C or in RNAlater
solution. As described previously,7 we categorized the
cases into different phenotypic subgroups. Nonscrotal
position was defined as distal if the most severely affected
cryptorchid testis was located at or beyond the external
inguinal ring and proximal if at least 1 testis was located
within the inguinal canal or abdomen. We assigned boys
2 years or younger to the early subgroup and those older
than 2 years to the late subgroup based on timing of
surgery by a pediatric urologist. Informed consent was
obtained for all participants based on approval of the
institutional review board at each participating center.
DNA was extracted from tissue or blood samples
(5 PRIME, Inc., Gaithersburg, Maryland), and whole
genome amplification (REPLI-g Mini Kit, Qiagen, Ger-
mantown, Maryland) was performed for those with low
DNA yield. Samples of adequate purity (optical density
260/280 ratio of 1.8 to 2.0 by NanoDrop 1000 spectro-
photometer) were entered into the standard genotyping
work flow at the Center for Applied Genomics at the
Children’s Hospital of Philadelphia. Two separate groups
were analyzed based on the genotyping platform used in
the discovery stage, according to availability of control
genotypes. Group 1 consisted of 559 cases and 1,772 con-
trols that were genotyped using HumanHap550, version 1
or 3, or Human610-Quad, version 1 BeadChip (Illumina).
These platforms have more than 535,000 SNPs in com-
mon. Group 2 consisted of 353 cases and 1,149 controls
that were genotyped using the Human OmniExpress 12,
version 1 BeadChip platform (Illumina).
Discovery Phase Data Analysis
Genome-wide genotyping data from groups 1 and 2 were
analyzed separately using PLINK, version 1.07 (http://
pngu.mgh.harvard.edu/wpurcell/plink/).8,9 SNP content
differed slightly for each of the 3 genotyping platforms
used in group 1. Therefore, only overlapping SNPs
(535,752) were used for subsequent analysis. Individuals
were excluded from further analysis due to 1) discordance
between reported sex and X and Y chromosome SNP
data, 2) missing genotype rate greater than 3%, 3) higher
or lower than expected heterozygosity rate (greater
than 3 SDs from mean) and 4) duplicates or relatives
(based on estimate of proportion of alleles shared identical
by descent greater than 0.1875). SNPs were excluded due
to 1) missing genotype rate greater than 5%, 2) Hardy-
Weinberg equilibrium deviation in controls (p <0.00001),
3) significantly different missing genotype rates between
cases and controls (p <0.00001), and 4) low minor allele
frequency (less than 0.01). To select samples of European
ancestry and control for population substructure, multi-
dimensional scaling analysis was performed in PLINK
using European population SNP genotyping data from
the Stanford Human Genome Diversity Project (http://
www.hagsc.org/hgdp/files.html).10 We removed all sam-
ples that deviated from the means of the first or second
components by more than 3 SDs. We performed separate
association analyses for the remaining samples in groups
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scaling components 1 and 2 as covariates.
We used HaploView, version 4.2 to define the pattern of
LD at the TGFBR3 locus (http://www.broadinstitute.org/
scientific-community/science/programs/medical-and-
population-genetics/haploview/haploview),11 and a targeted
region was chosen for imputation (Chr1:91960000-
92415000, GRCh37/hg19 assembly). Genotype data in
PLINK format were converted to IMPUTE, version 2.3.0
file format,12,13 using GTOOL, version 0.7.5 (http://www.
well.ox.ac.uk/wcfreeman/software/gwas/gtool.html). We
performed imputation using the 1000 Genomes Project
reference population (September 2013 version), followed
by association analysis of imputed data using IMPUTE2
and SNPTEST, version 2.5b (https://mathgen.stats.ox.ac.
uk/genetics_software/snptest/old/snptest_v2.3.0.html),
respectively.12,13 Imputed SNPs were removed from
SNPTEST results based on the criteria minor allele fre-
quency less than 0.01, control Hardy-Weinberg equilib-
rium less than 0.00001 and frequentist_add_info
(imputation quality score) less than 0.8. Meta-analyses of
the remaining SNPs for groups 1 and 2 was performed
using META, version 1.5 (http://www.stats.ox.ac.uk/
wjsliu/meta.html) for all cases and controls, and for sub-
groups defined by testicular position, laterality and
timing of presentation. Differences in phenotype fre-
quencies between the 2 discovery groups were analyzed
using chi-square tests. Results were mapped using the
SNAP Web tool (http://www.broadinstitute.org/mpg/snap/),14
and LD among the strongest signals was estimated using
HaploView.
Replication Phase
DNA samples from boys with cryptorchidism and unaf-
fected controls were obtained in a prior study of cryptor-
chidism in Sweden.15e17 We selected the top TGFBR3
signals from groups 1 and 2, or an SNP in complete LD,
and the previously published marker rs12082710 for
genotyping using TaqMan assays.6 Genotyping was
performed in a 384-well format using the Applied Bio-
systems PRISM 7900HT fast real-time polymerase
chain reaction system. A reaction volume of 5 ml included
1.25 ml water, 2.5 ml 2  Applied Biosystems genotyping
master mix, 0.25 ml 20  TaqMan genotyping assay and
1 ml (15 ng) genomic DNA. The polymerase chain reaction
conditions were 95C for 10 minutes, followed by 50 cycles
at 95C for 15 seconds and 60C for 60 seconds. The geno-
typing calls were made by Applied Biosystems SDS
Automation Controller software, version 2.3. Association
tests were performed using online software (http://ihg.gsf.
de/cgi-bin/hw/hwa1.pl). A description of supplementary
methods used to conduct real-time quantitative polymer-
ase chain reaction and immunostaining is available
online (http://jurology.com/).18e20RESULTS
Based on quality control criteria, 56 of 559 cases,
158 of 1,772 controls and 28,749 of 535,752 markers
were removed from group 1, and 12 of 353 cases,
45 of 1,149 controls and 89,489 of 719,629 markers
were removed from group 2, leaving 844 cases and2,718 controls in the final analysis. Q-Q plots of the
distribution of p values in groups 1 and 2 did not
exhibit significant deviation from their expected
distribution, with genomic inflation factor (l) values
of 1.014 and 1.017, respectively.
There were no genome-wide significant
(p <5.0108) signals in analyses of the 2 subsets
in the discovery phase (groups 1 and 2), but
we identified TGFBR3 (chr1:92145900-92371559,
reverse strand, GRCh37/hg19 assembly) as the only
genomic region containing suggestive (p 1104)
markers for both groups. In light of the previous
data suggesting a possible association of TGFBR3
with TDS and cryptorchidism,6 we focused on this
region initially. Following imputation the strongest
signals were rs9661103 (p ¼ 2.71105), located in
intron 1, and rs10782968 (p ¼ 9.38105), located
approximately 101 kb downstream between
TGFBR3 and CDC7, for groups 1 and 2, respectively
(fig. 1, table 1). However, the reciprocal analysis
revealed no evidence of association of 30 down-
stream or 50 intragenic SNPs with groups 1 and 2,
respectively, so these signals were weaker when we
combined discovery data for groups 1 and 2 in a
meta-analysis. In addition, we observed marginal
(OR 1.13, 95% CI 0.99e1.28 p ¼ 0.09) association of
rs12082710 with group 1 but not group 2 cases.
However, the RAF in our control samples (0.62) was
higher than previously reported (0.58 to 0.59) for
this variant,6 and, therefore, was similar to the
RAF in our case groups. In the replication phase
available genotypes of 305 cases and 324 unaffected
controls collected from white subjects in Sweden
failed to show association of any of these markers
with cryptorchidism (table 1).
We performed additional analyses to determine
whether phenotypic heterogeneity between our
2 case groups could potentially account for these
variable results. Testicular position, laterality
and/or age at presentation data were available for at
least 90% of affected individuals in each classifica-
tion (table 2). We noted increased frequencies of
proximal, bilateral and early presentation in group
1 as compared to group 2, although these trends
were not statistically significant. However, in meta-
analyses of subphenotypes we noted strongest evi-
dence of association of proximal and distal testicular
positioning with upstream/promoter and down-
stream regions of TGFBR3, respectively (fig. 2,
supplementary table [http://jurology.com/]). For the
additional meta-analyses based on laterality and
age at presentation all associations were weaker.
Using HaploView, we reviewed the LD patterns
for the top signals in the 2 genotyping groups and
the position subgroups. The strongest signals in
group 1 (rs9661103) and group 2 (rs10782968)
analyses are not in LD with each other, but were
Figure 1. SNAP plots demonstrate association analysis results of imputed data. A, group 1 cases and controls. B, group 2 cases and
controls. C, meta-analysis of all cases and controls.
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Table 1. Results of single marker association analysis in discovery and replication groups
RAF Cases RAF Controls OR (95% CI) p Value
Discovery group 1
Marker rs6687904, position 92025262, risk allele G 0.89 0.87 1.20 (0.96, 1.50) 5.03E-02
Marker rs925192, position 92038225, risk allele T 0.83 0.82 1.01 (0.84, 1.22) 0.62
Marker rs10782968, position 92044755, risk allele T 0.79 0.78 1.02 (0.86, 1.21) 0.62
Marker rs12082710, position 92155337, risk allele T 0.65 0.62 1.13 (0.99, 1.28) 0.09
Marker rs9661103, position 92335906, risk allele C 0.74 0.67 1.40 (1.20, 1.64) 2.71E-05
Discovery group 2
Marker rs6687904, position 92025262, risk allele G 0.90 0.85 1.50 (1.40, 1.98) 1.91E-03
Marker rs925192, position 92038225, risk allele T 0.87 0.80 1.66 (1.29, 2.13) 1.12E-04
Marker rs10782968, position 92044755, risk allele T 0.84 0.76 1.58 (1.26, 1.98) 9.38E-05
Marker rs12082710, position 92155337, risk allele T 0.62 0.62 1.01 (0.85, 1.20) 0.74
Marker rs9661103, position 92335906, risk allele C 0.70 0.69 1.01 (0.84, 1.22) 0.88
Discovery meta-analysis
Marker rs6687904, position 92025262, risk allele G 1.35 (1.14, 1.60) 5.82E-04
Marker rs925192, position 92038225, risk allele T 1.23 (1.07, 1.43) 5.29E-03
Marker rs10782968, position 92044755, risk allele T 1.22 (1.06, 1.39) 4.22E-03
Marker rs12082710, position 92155337, risk allele T 1.07 (0.95, 1.18) 0.27
Marker rs9661103, position 92335906, risk allele C 1.23 (1.09, 1.38) 7.94E-04
Replications
Marker rs6687904, position 92025262, risk allele G
Marker rs925192, position 92038225, risk allele T 0.82 0.81 1.07 (0.80, 1.43) 0.63
Marker rs10782968, position 92044755, risk allele T
Marker rs12082710, position 92155337, risk allele T 0.62 0.61 1.04 (0.83, 1.30) 0.83
Marker rs9661103, position 92335906, risk allele C 0.65 0.69 0.84 (0.66, 1.06) 0.14
Markers shown include top signals (in bold) identified in groups 1 (rs9661103) and 2 (rs10782968 and rs925192) in present study, meta-analysis (rs6687904) and series by
Dalgaard et al (rs12082710).6
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most significant SNPs that we identified in the
proximal (rs17576372) and distal (rs6687904)
meta-analyses (figs. 1 to 3), consistent with a
greater frequency of proximal cases in group 1.
These results suggest that phenotypic bias may be
1 factor accounting for the nonoverlapping signals
we identified in separate analyses of our discovery
groups.
In studies of rat gubernaculum Tgfbr3 mRNA
levels did not change significantly in wt samples
between E17 and E21 (p ¼ 0.57), the maximal
developmental period (fig. 4). In contrast, Tgfbr3
expression increased after E17 (p ¼ 0.055) and
was significantly greater in cryptorchid orl at E19
(p ¼ 0.011) and E21 (p ¼ 0.001) compared to wt
gubernaculum. In wt gubernacular explants INSL3
exposure did not alter measured Tgfbr3 expression,
but transcript levels increased significantly
following DHT exposure (p <0.01 for 10 nM DHT).Table 2. Frequency of specific phenotypes by group
Phenotype Group 1 Group 2 p Value
No. position (%): 0.47
Proximal 167 (35) 107 (32)
Distal 313 (65) 224 (68)
No. laterality (%): 0.21
Bilat 137 (28) 80 (24)
Unilat 360 (72) 258 (76)
No. presentation (%): 0.07
Early 236 (48) 142 (42)
Late 255 (52) 198 (58)Immunostaining of the rat fetal gubernaculum
demonstrated diffuse TGFBR3 protein expression
within the inner mesenchymal core but more
intense staining of the developing peripheral muscle
and outer mesothelial layer, as noted in E17 and
E19 wt gubernacula (fig. 5, A). The muscle layer
was adjacent to the mesothelial layer at E17 and
became progressively less peripheral and thicker
during development. Prominent clusters of beta-
glycan (TGFBR3-A positive) immunoreactivity
consistent with the proteolytically cleaved extra-
cellular domain (soluble betaglycan) revealed vari-
able expression at all time points, along with
coexpression of membrane associated betaglycan
and myosin in differentiated muscle. These extra-
cellular collections were not identified using
TGFBR3-B, an antibody targeting cytoplasmic
betaglycan, and expression was less prominent by
E21 in wt and orl samples. These collections were
particularly prominent in some orl samples, partic-
ularly within the mesenchymal core and the pe-
ripheral mesothelial layer (fig. 5, B).DISCUSSION
Cryptorchidism is the most common reproductive
anomaly identified in newborn boys but genetic
susceptibility loci remain largely undefined. In the
sole published GWAS that includes cryptorchidism
TGFBR3 was identified as a locus associated with
TDS and less strongly with isolated nonsyndromic
cryptorchidism, although the data did not approach
Figure 2. SNAP plots of meta-analysis results of imputed data at TGFBR3 locus. A, cryptorchid cases with testes located proximal to
external inguinal ring and all controls. B, cryptorchid cases with testes located distal to external inguinal ring.
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the larger sample size provided increased power to
detect an association of TGFBR3 with cryptorchi-
dism. Although we showed nominal association
of our group 1 cohort with the previously reportedsignal, this association was lost with increasing
sample size and was not replicated in a Swedish
population. Surprisingly we observed suggestive
(p <104) association of each of our case-control
groups with independent signals at or near the
Figure 3. LD plot of markers identified in primary group
and subgroup analyses (available in HaploView). Lower
portion of figure illustrates overview of LD blocks within
imputed TGFBR3 locus. Black rectangle is centered on 30 end
of TGFBR3 gene.
Figure 5. A, betaglycan expression (green stain) in E17, E19
and E21 gubernacula from wt and cryptorchid orl fetuses.
Immunostaining reveals myosin (differentiated muscle, red)
and TGFBR3-A (extracellular domain, green, top 2 rows) or
TGFBR3-B (cystoplasmic domain, green, bottom 2 rows).
Reduced from 20 (scale bar 100 mm). B, immunostaining
for TGFBR3-A (green, 1:50), myosin (red) and nuclei (DAPI,
blue) in E21 gubernaculum shows prominent soluble
betaglycan collections in some fetuses. Reduced from 10
(scale bar 200 mm).
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stronger association of proximal and distal pheno-
types with linked SNPs in the 50 and downstreamFigure 4. Tgfbr3 mRNA expression in gubernaculum from
wt and cryptorchid orl rat fetuses. Baseline expression is
illustrated for freshly isolated E17, E19 and E21 gubernacula
and for E17 wt gubernacular explants established in culture
followed by exposure to INSL3 or DHT for 24 hours. Asterisk
indicates p <0.05 for wt vs orl. Double asterisk signifies
p <0.01 for wt vs orl.regions of the gene, respectively. HapMap data
(http://hapmap.ncbi.nlm.nih.gov/cgi-perl/gbrowse/
hapmap24_B36/) demonstrate minimal LD be-
tween these 3 genomic regions. It is possible that
the strength of the observed association for any
1 signal is limited by allelic heterogeneity and/or
the unmeasured effects of variable environmental
exposures.
Cryptorchidism is a complex disease, likely
influenced by multilocus genetic, maternal and/or
environmental factors. The genomic loci and path-
ways involved remain largely unknown, although
many studies address this question in animal
models. Gene targeting experiments in mice confirm
requirement for Rxfp2 and Ar, substantiate a role
for Wnt and Notch signaling in gubernacular
development, and confirm myogenesis as a key
target of hormone action.21,22
TGFBR3/betaglycan is a biologically compelling
risk locus for cryptorchidism because of its associa-
tion with fetal Leydig cell development and myo-
genesis.23,24 Betaglycan is a TGFb coreceptor that
facilitates or inhibits signaling, depending on
the context.25 The cytoplasmic domain facilitates
1644 PHENOTYPE SPECIFIC ASSOCIATION OF TGFBR3 LOCUS WITH CRYPTORCHIDISMsignaling by TGFb2 or TGFb1, while the soluble,
cleaved ectodomain can modulate TGFb signaling
by sequestering these growth factors. Betaglycan is
expressed in interstitial and peritubular myoid
cells in the fetal testes of mice and humans.26,27
Tgfbr3 -/- mice exhibit disruption of tubular archi-
tecture and a transient delay in Leydig cell devel-
opment, with reduced expression of Insl3 and
steroidogenesis genes.24 It is noteworthy that inac-
tivation of Tgfb2 in transgenic mice is associated
with cryptorchidism without other external genital
defects,28 suggesting a primary gubernacular defect
rather than global hormone deficiency. This and
previous studies revealing expression of Tgfbr3 and
Tgfb2 with increased expression in orl and wt males
following androgen exposure support a role for
TGFb signaling in gubernaculum development.18,20
The present data suggest that membrane asso-
ciated betaglycan is expressed throughout the fetal
rat gubernaculum but most strongly in the outer
mesothelial layer and in association with areas of
developing muscle, and that focal increased accu-
mulation of soluble betaglycan occurs in mesothe-
lium and mesenchyme of orl gubernacula. Although
we have not fully elucidated the genomic loci that
confer susceptibility to cryptorchidism, our prior
studies suggest that androgen signaling and muscle
patterning are altered in the orl strain.20,29Inconsistency in the pattern of association of
TGFBR3 with cryptorchidism may reflect various
factors, notably insufficient sample size, allelic het-
erogeneity, population differences and/or phenotypic
misclassification or variability. Regarding the
latter, Dalgaard et al included subjects identified
at birth or through medical records,6 although it is
unclear whether all had persistent cryptorchidism
requiring surgery. In their discussion of the
concept of “synthetic” association of GWAS signals
with rare, causal variants in the same genomic re-
gion Dickson et al also hypothesized that even
modest associations defined by GWAS may show
loci that contain rare variants of larger effect.30CONCLUSIONS
The present data warrant more intensive investi-
gation to define potential causal variants and the
role of betaglycan in reproductive development in
experimental animal models. Hypotheses that
should be addressed include the possibility that
genomic loci participate in hormone signaling
pathways that are also specific targets of environ-
mental exposures, and that pleiotropic effects of
genes may explain the co-occurrence of testicular
germ cell defects (cancer and subfertility) and
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